Market Cap (In USD)
377.4 Thousand
Revenue (In USD)
62.5 Thousand
Net Income (In USD)
-9.32 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0026-0.0026
- PE
- -
- EPS
- -
- Beta Value
- -0.393
- ISIN
- -
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Mr. Wern-Yi Goh B.Com., M.B.A.
- Employee Count
- -
- Website
- https://www.achiko.com
- Ipo Date
- 2021-02-17
- Details
- Achiko AG engages in developing disruptive diagnostic solutions in Indonesia and internationally. The company's lead product is AptameX, a rapid test that uses DNA aptamers instead of antigens to detect the SARS-CoV-2 virus. It also offers Teman Sehat, a mobile check-in and passport application. In addition, the company provides secure payment solutions for game publishers and application developers to accept various payment methods for digital contents and goods under the Mimopay brand, as well as develops game software. Achiko AG was incorporated in 2018 and is headquartered in Zurich, Switzerland.
More Stocks
-
ADKDIAGNOS Inc.
ADK
-
WPL
-
AZNCFAstraZeneca PLC
AZNCF
-
MOSTQMobileSmith, Inc.
MOSTQ
-
4385Mercari, Inc.
4385
-
OPINL
-
OPNT
-
MRT